Page 18 - 53-Peptic ulcer diseases (Loét dạ dày)

References 819.e3

93. Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac 114. Jensen DM, Kovacs TO, Jutabha R, et al. Randomized trial of medi-
plus omeprazole in high-risk arthritis patients: results of a random- cal or endoscopic therapy to prevent recurrent ulcer hemorrhage 53
ized double-blind trial. Gastroenterology 2004;127:1038–43. in patients with adherent clots. Gastroenterology 2002;123:407–13.
94. Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-ox- 115.
ygenase-2 inhibitor and a proton pump inhibitor for prevention of 115. Bleau BL, Gostout CJ, Shearman KE, et al. Recurrent bleeding
recurrent ulcer bleeding in patients at very high risk: a double-blind from peptic ulcer associated with adherent clot: a randomized study
randomized trial. Lancet 2007;369:1621–6. comparing endoscopic treatment with medical therapy. Gastrointest
95. Bombardier C, Laine L, Reicin A, et al. Comparison of upper Endosc 2002;56:1–6.
gastrointestinal toxicity of rofecoxib and naproxen in patients 116. Kahi CJ, Jensen DM, Sung JJ, et al. Endoscopic therapy versus med-
with rheumatoid arthritis. VIGOR study group. N Engl J Med ical therapy for bleeding peptic ulcer with adherent clot: a meta-
2000;343:1520–8. analysis. Gastroenterology 2005;129:855–62.
96. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events as- 117. Johnston JH. The sentinel clot and invisible vessel: pathologic anat-
sociated with rofecoxib in a colorectal adenoma chemoprevention omy of bleeding peptic ulcer. Gastrointest Endosc 1984;30:313–5.
trial. N Engl J Med 2005;352:1092–102. 118. Jensen DM, Ohning GV, Kovacs TOG, et al. Doppler endoscopic
97. 1SD, McMurray JJV, Pfeffer MA, et al. For the Adenoma Preven- probe as a guide to risk stratification an definitive hemostasis of pep-
tion with Celecoxib (APC) Study Investigators. Cardiovascular risk tic ulcer bleeding. Gastrontest Endosc 2016;83:129–36.
associated with celecoxib in a clinical trial for colorectal adenoma 119. Jensen DM, Kovacs TOG, Ohning GV, et al. Doppler endoscopic
prevention. N Engl J Med 2005;352:1071–80. probe monitoring of blood flow improves risk stratification and
98. Cannon CP, Curtis SP, FitzGerald GA, et al. Cardiovascular out- outcomes of patients with severe nonvariceal upper gastrointestinal
comes with etoricoxib and diclofenac in patients with osteoarthritis hemorrhage. Gastroenterology 2017;152:1310–8.
and rheumatoid arthritis in the Multinational Etoricoxib and Di- 120. Vergara M, Bennett C, Calvet X, Gisbert JP. Epinephrine injec-
clofenac Arthritis Long-term (MEDAL) programme: a randomised tion versus epinephrine injection and a second endoscopic meth-
comparison. Lancet 2006;368:1771–81. od in high risk bleeding ulcers. Cochrane Database Syst Rev
99. McGettigan P, Henry D. Cardiovascular risk and inhibition of cy- 2014;(10):CD005584.
clooxygenase: a systematic review of the observational studies of se- 121. Sung JJ, Tsoi KK, Lai LH, et al. Endoscopic clipping versus injec-
lective and nonselective inhibitors of cyclooxygenase 2. J Am Med tion and thermocoagulation in the treatment of non-variceal upper
Assoc 2006;296:1633–44. gastrointestinal bleeding: a meta-analysis. Gut 2007;56:1364–73.
100. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety 122. Schmidt A, Golder S, Goetz M, et al. Over-the-scope clips are
of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med more effective than standard endoscopic therapy for patients with
2016;375(26):2519–29. recurrent bleeding of peptic ulcers. Gastroenterology 2018;05:037.
101. Chan FKL, Ching JYL, Tse YK, et al. Gastrointestinal safety of ce- [Epub ahead of print].
lecoxib versus naproxen in patients with cardiothrombotic diseases 123. Labenz J, Peitz U, Leusing C, et al. Efficacy of primed infusions
and arthritis after upper gastrointestinal bleeding (CONCERN): an with high-dose ranitidine and omeprazole to maintain high intra-
industry-independent, double-blind, double-dummy, randomised gastric pH in patients with peptic ulcer bleeding: a prospective ran-
trial. Lancet 2017;389:2375–82. domised controlled study. Gut 1997;40:36–41.
102. Pearson TA, Blair SN, Daniels SR, et al. AHA scientific statement: 124. Sung JJY, Barkum A, Kuipers EJ, et al. Intravenous esomeprazole
AHA guidelines for primary prevention of cardiovascular disease for prevention of recurrent peptic ulcer bleeding. Ann Int Med
and stroke: 2002 Update, 71-0226. Circulation 2002;106:388–91. 2009;150:455–64.
103. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastroin- 125. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor
testinal bleeding in the UK: patient characteristics, diagnoses and treatment for acute peptic ulcer bleeding. Cochrane Database Syst
outcomes in the 2007 UK audit. Gut 2011;60:1327–35. Rev 2006;25:CD902094.
104. Barkun A, Bardou M, Kuipers EJ, et al. International consensus 126. Neumann I, Letelier LM, Rada G, et al. Comparison of different
recommendations on the management of patients with nonvariceal regimens of proton pump inhibitors for acute peptic ulcer bleeding.
upper gastrointestinal bleeding. Ann Intern Med 2010;152:101–13. Cochrane Database Syst Rev 2013;60:CD007999.
105. Lin HJ, Wang K, Perng CL, et al. Early or delayed endoscopy for 127. Lau JY, Leung WK, Wu JC, et al. Omeprazole before endos-
patients with peptic ulcer bleeding: a prospective randomized con- copy in patients with gastrointestinal bleeding. N Engl J Med
trolled trial. J Clin Gastroenterol 1996;22:267–71. 2007;356:1631–40.
106. Lee JG, Turnipseed S, Romano PS, et al. Endoscopy-based triage 128. Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hos-
significantly reduces hospitalization rates and costs of treating up- pitalizations for peptic ulcer disease in the united states, 1993 to
per GI bleeding: a randomized controlled trial. Gastrointest Endosc 2006. Ann Surg 2010;251:51–8.
1999;50:755–61. 129. Jairath V, Kahan BC, Logan RF, et al. National audit of the use
107. Cipolletta L, Bianco MA, Rotondano G, et al. Outpatient manage- of surgery and radiological embolization after failed endoscopic he-
ment for low-risk nonvariceal upper GI bleeding: a randomized mostasis for non-variceal upper gastrointestinal bleeding. Br J Surg
controlled trial. Gastrointest Endosc 2002;55:1–5. 2012;99:1672–80.
108. Barkun A, Martel M, Toubouti Y, Rahme E, Bardou M. Endoscopic 130. Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review
hemostasis in peptic ulcer bleeding for patients with high-risk le- of the predictors of recurrent hemorrhage after endoscopic he-
sions: a series of meta-analyses. Gastrointest Endosc 2009;69:786– mostatic therapy for bleeding peptic ulcer. Am J Gastroenterol
99. 2008;103:2625–32.
109. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment 131. Lau JY, Sung JJY, Lam YH, et al. Endoscopic re-treatment com-
after acute upper gastrointestinal haemorrhage. Gut 1996;38:316– pared with surgery in patients with recurrent bleeding after initial
21. endoscopic control of bleeding ulcers. N Engl J Med 1999;340:751–
110. Blatchford O, Murray WR, Blatchford M. A risk score to predict 6.
need for treatment for upper gastrointestinal haemorrhage. Lancet 132. Poxon VA, Keighley MRB, Dykes PW, et al. Comparison of mini-
2000;356:1318–21. mal and conventional surgery in patients with bleeding ulcer: A mul-
111. Stanley AJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R, et al. ticentre trial. Br J Surg 1991;78:1344–5.
Comparison of risk scoring systems for patients presenting with up- 133. Millat B, Hay JM, Valleur P, et al. Emergency surgical treatment
per gastrointestinal bleeding: international multicentre prospective for bleeding duodenal ulcer: oversewing plus vagotomy versus gas-
study. BMJ 2017;356:6432. tric resection, a controlled randomized trial french associations for
112. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointes- surgical research. World J Surg 1993;17:568–74.
tinal bleeding. Lancet 1974;2:394–7. 134. Schroder VT, Pappas T, Vaslef S, et al. Vagotomy/Drainage is su-
113. Laine L, Jensen DM. Management of patients with ulcer bleeding. perior to local oversew in patients who require emergency surgery
Am J Gastroenterol 2012;107:345–60. for bleeding peptic ulcers. Ann Surg 2014;259:1111–8.